Spyre Therapeutics, Inc. logo

Spyre Therapeutics, Inc. (SYRE)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
100. 23
+6.11
+6.4917%
$
5.9B Market Cap
- P/E Ratio
- Div Yield
1.09M Volume
- Eps
$ 94.12
Previous Close
Add Transaction
Day Range
92.37 101.36
Year Range
14.51 105.09
Want to track SYRE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Spyre Therapeutics, Inc. logo
SYRE Spyre Therapeutics, Inc.
6 May 2026
-
-
Spyre Therapeutics, Inc. logo
SYRE Spyre Therapeutics, Inc.
26 Feb 2026
-
-
Spyre Therapeutics, Inc. logo
SYRE Spyre Therapeutics, Inc.
5 Nov 2025
-
-
Spyre Therapeutics, Inc. logo
SYRE Spyre Therapeutics, Inc.
31 Jul 2025
-
-
Spyre Therapeutics, Inc. logo
SYRE Spyre Therapeutics, Inc.
13 May 2025
-
-
Spyre Therapeutics, Inc. logo
SYRE Spyre Therapeutics, Inc.
26 Feb 2025
-
-

SYRE Earnings Reports FAQ

What is the earnings per share (EPS) for SYRE?

EPS data for SYRE is currently not available, as Spyre Therapeutics, Inc has not reported recent earnings.

What is the company's earnings growth rate?

Spyre Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Spyre Therapeutics, Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Spyre Therapeutics, Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for SYRE at this time, as Spyre Therapeutics, Inc has no recent EPS data to calculate it.